About Quanterix
Quanterix is a company based in Cambridge (United States) founded in 2007.. Quanterix has raised $99.5 million across 15 funding rounds from investors including General Electric, T. Rowe Price and Hercules Capital. The company has 471 employees as of December 31, 2024. Quanterix has completed 2 acquisitions, including Akoya Biosciences and UmanDiagnostics. Quanterix offers products and services including Simoa Assay Kits, Simoa HD-X Analyzer, and Custom Assay Development. Quanterix operates in a competitive market with competitors including Bio Rad, Horizon Discovery, Siemens Healthineers, Merck and Arrakis Therapeutics, among others.
- Headquarter Cambridge, United States
- Employees 471 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Quanterix Corporation
-
Annual Revenue
$137.42 M12.3as on Dec 31, 2024
-
Net Profit
$-38.53 M-35.89as on Dec 31, 2024
-
EBITDA
$-44.26 M-35.51as on Dec 31, 2024
-
Total Equity Funding
$99.5 M (USD)
in 15 rounds
-
Latest Funding Round
-
Investors
General Electric
& 13 more
-
Employee Count
471
as on Dec 31, 2024
-
Investments & Acquisitions
Akoya Biosciences
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Quanterix
Quanterix is a publicly listed company on the NASDAQ with ticker symbol QTRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Quanterix
Quanterix offers a comprehensive portfolio of products and services, including Simoa Assay Kits, Simoa HD-X Analyzer, and Custom Assay Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kits for ultrasensitive protein biomarker measurement in research.
Automated platform for precise immunoassay detection.
Tailored solutions for specialized biomarker research needs.
Unlock access to complete
Unlock access to complete
Leadership Team
26 people
Senior Team
8 people
Finance and Accounting
6 people
Sales and Marketing
6 people
Product Management Team
5 people
Human Resources and Administration
3 people
Operations Team
2 people
Software Development Team
2 people
Unlock access to complete
Funding Insights of Quanterix
Quanterix has successfully raised a total of $99.5M across 15 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Last Round
-
First Round
First Round
(29 Jul 2008)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Grant - Quanterix | Valuation |
investors |
|
| Jun, 2017 | Amount | Series D - Quanterix | Valuation | T. Rowe Price |
|
| Mar, 2016 | Amount | Series D - Quanterix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Quanterix
Quanterix has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include General Electric, T. Rowe Price and Hercules Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Quanterix
Quanterix has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Akoya Biosciences and UmanDiagnostics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of solutions for rapid proteomic profiling
|
2015 | ||||
|
Rapid ELISA tests for MS, ALS, and PD are developed.
|
2006 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Quanterix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quanterix Comparisons
Competitors of Quanterix
Quanterix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Horizon Discovery, Siemens Healthineers, Merck and Arrakis Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| domain | founded_year | HQ Location |
Genetically modified cell lines are developed using AAV gene-editing platform.
|
|
| domain | founded_year | HQ Location |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Quanterix
Frequently Asked Questions about Quanterix
When was Quanterix founded?
Quanterix was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Quanterix located?
Quanterix is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Quanterix a funded company?
Quanterix is a funded company, having raised a total of $99.5M across 15 funding rounds to date. The company's 1st funding round was a Series D of $46M, raised on Jul 29, 2008.
How many employees does Quanterix have?
As of Dec 31, 2024, the latest employee count at Quanterix is 471.
What is the annual revenue of Quanterix?
Annual revenue of Quanterix is $137.42M as on Dec 31, 2024.
What does Quanterix do?
Quanterix was founded in 2007 in Cambridge, United States, and operates in the biotechnology sector. Assay kits utilizing the Simoa technology are provided for ultra-sensitive biomarker detection. This solution supports research applications across oncology, neurology, cardiology, inflammation, and infectious diseases. Operations focus on enabling disease detection, prognosis, and treatment methods through precise biomarker analysis.
Who are the top competitors of Quanterix?
Quanterix's top competitors include Horizon Discovery, Biocare Medical and NanoString.
What products or services does Quanterix offer?
Quanterix offers Simoa Assay Kits, Simoa HD-X Analyzer, and Custom Assay Development.
Is Quanterix publicly traded?
Yes, Quanterix is publicly traded on NASDAQ under the ticker symbol QTRX.
How many acquisitions has Quanterix made?
Quanterix has made 2 acquisitions, including Akoya Biosciences, and UmanDiagnostics.
Who are Quanterix's investors?
Quanterix has 14 investors. Key investors include General Electric, T. Rowe Price, Hercules Capital, HHS, and NFL.
What is Quanterix's ticker symbol?
The ticker symbol of Quanterix is QTRX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.